Business description: C-Rad AB

C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.

Number of employees: 98

Sales by Activity: C-Rad AB

Fiscal Period: December 2021 (SEK) 2022 (SEK) 2023 (SEK) 2024 (SEK) 2025 (SEK)

Positioning

261M 301M 425M 469M 442M

Geographical breakdown of sales: C-Rad AB

Fiscal Period: December 2021 (SEK) 2022 (SEK) 2023 (SEK) 2024 (SEK) 2025 (SEK)

EMEA (Excluding Sweden)

- - - - 168M

APAC

- - 119M 210M 167M

Americas

- - 85.97M 72.7M 98.75M

Sweden

21.73M 8.67M - - 8.57M

South and Latin America

655K 689K - - -

Dach (Germany, Austria, Switzerland)

40.6M 31.88M - - -

The Rest of The Nordic Countries

5.37M 12.11M - - -

EMEA

- - 220M 186M -

France

13.91M 15.27M - - -

ROE (Other Europe)

46.27M 77.98M - - -

Asia

82.07M 83.99M - - -

USA

50.55M 70.75M - - -

Executive Committee: C-Rad AB

Manager TitleAgeSince
Chief Executive Officer 56 02/02/2026
Chief Executive Officer - 21/10/2025
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer 58 01/11/2019
Corporate Officer/Principal 58 21/10/2025

Composition of the Board of Directors: C-Rad AB

Director TitleAgeSince
Director/Board Member 52 01/01/2017
Director/Board Member 60 07/05/2021
Chairman 61 05/05/2023
Director/Board Member 60 05/05/2023
Director/Board Member 66 05/05/2023
Director/Board Member 55 23/07/2007

Shareholders: C-Rad AB

NameStocks%Valuation
Svea Bank AB
11.93 %
3,924,969 11.93 % 15 M €
9.926 %
3,266,170 9.926 % 13 M €
Cervantes Capital AB
9.072 %
2,984,997 9.072 % 11 M €
4.352 %
1,432,078 4.352 % 6 M €
3.647 %
1,200,000 3.647 % 5 M €
NameStocks%Valuation
44.01 %
379,762 44.01 % 1 M €
30.49 %
263,125 30.49 % 1 M €
Cervantes Capital AB
13.91 %
120,000 13.91 % 461 635 €
Svea Bank AB
11.59 %
100,000 11.59 % 384 696 €

Holdings: C-Rad AB

NameStocks%Valuation
188,5000.57% 725 152 $

Company details: C-Rad AB

C-RAD AB

Sjukhusvaegen 12K

753 09, Uppsala

+46 18 666 930

http://www.c-rad.se
address C-Rad AB(24C)

Other Advanced Medical Equipment & Technology

Change 5-day change 1-year change 3-year change Capi.($)
-1.35%-1.13%+26.27%+11.30% 230B
+0.18%-1.27%+4.98%-18.21% 152B
+1.51%-1.64%-21.28%+16.96% 132B
+0.36%-7.01%-55.60%-13.69% 67.88B
+0.29%+0.47%+10.90%+15.92% 52B
+0.66%-1.69%-16.47%-13.96% 51.05B
-2.44%-3.25%+22.43%+25.40% 43.38B
-1.56%+0.97%+37.41%+44.40% 40.74B
+1.94%+3.81%-12.45%+46.38% 34.67B
Average -0.10%-1.19%-0.42%+12.72% 89.25B
Weighted average by Cap. -0.17%-1.46%+2.51%+7.18%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
35.40SEK
Average target price
45.00SEK
Spread / Average Target
+27.12%

Quarterly revenue - Rate of surprise